- Home
- BCDA vs JVA Comparison
BCDA vs JVA Comparison
Compare BCDA & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- JVA
- Stock Information
- Founded
- BCDA N/A
- JVA 1971
- Country
- BCDA United States
- JVA United States
- Employees
- BCDA N/A
- JVA N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- JVA Packaged Foods
- Sector
- BCDA Health Care
- JVA Consumer Staples
- Exchange
- BCDA Nasdaq
- JVA Nasdaq
- Market Cap
- BCDA 10.1M
- JVA 24.7M
- IPO Year
- BCDA N/A
- JVA 2005
- Fundamental
- Price
- BCDA $2.39
- JVA $4.50
- Analyst Decision
- BCDA Strong Buy
- JVA
- Analyst Count
- BCDA 1
- JVA 0
- Target Price
- BCDA $25.00
- JVA N/A
- AVG Volume (30 Days)
- BCDA 230.7K
- JVA 227.0K
- Earning Date
- BCDA 08-12-2025
- JVA 06-13-2025
- Dividend Yield
- BCDA N/A
- JVA N/A
- EPS Growth
- BCDA N/A
- JVA 856.08
- EPS
- BCDA N/A
- JVA 0.65
- Revenue
- BCDA $3,000.00
- JVA $84,651,329.00
- Revenue This Year
- BCDA N/A
- JVA N/A
- Revenue Next Year
- BCDA N/A
- JVA N/A
- P/E Ratio
- BCDA N/A
- JVA $6.97
- Revenue Growth
- BCDA N/A
- JVA 15.86
- 52 Week Low
- BCDA $1.63
- JVA $1.50
- 52 Week High
- BCDA $4.66
- JVA $9.93
- Technical
- Relative Strength Index (RSI)
- BCDA 58.67
- JVA 57.42
- Support Level
- BCDA $1.98
- JVA $4.15
- Resistance Level
- BCDA $2.45
- JVA $4.54
- Average True Range (ATR)
- BCDA 0.17
- JVA 0.28
- MACD
- BCDA 0.04
- JVA -0.01
- Stochastic Oscillator
- BCDA 88.00
- JVA 61.54
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.